Please assess the completion status of the following clinical trial:

Trial Title: Texting to Improve Adherence in HIV+ With Bipolar Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ability to provide informed consent~* 18 years or older at the time of enrollment~* HIV-infected~* DSM-IV diagnosis Bipolar Disorder~* Taking at least one medication to treat HIV illness~* Taking at least one medication to treat bipolar disorder~* Indication of less than 100% adherence to antiretroviral (ART) medication~* Willingness to use electronic monitoring caps to track ART medication and BD medication~* Willingness to respond to text messages~Exclusion Criteria:~* Axis I psychiatric diagnosis of psychotic spectrum disorder (e.g., schizophrenia)~* Presence of a neurological condition (beyond HIV infection) known to impact cognitive functioning (e.g., Huntington's Disease, Stroke)~* Unwillingness or inability to use electronic medication monitoring technology~* Unwillingness or inability to use daily texting

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Personalized Reminder Texting + Psychoeducation (iTAB) (Type: EXPERIMENTAL): Participants in the individualized Texting for Adherence Building (iTAB) arm will receive daily text messaging reminders for antiretroviral and psychotropic medication adherence. These text messages will be targeted to the specific schedule and needs of the individual. Participants will also receive a text message that assesses mood. Finally, participants will receive a one-time psychoeducational intervention reviewing the importance of adherence to anti-HIV and psychotropic medications.
- Psychoeducation (CTRL) (Type: ACTIVE_COMPARATOR): Participants will receive a one-time psychoeducational intervention reviewing the importance of adherence to anti-HIV and psychotropic medications. They will also receive daily text messages to assess mood, but these messages will not receive the medication reminder text messages.

Based on this trial design, predict the completion outcome and termination type (if applicable).